Yanni Souroutzidis

Stock Analyst at Cantor Fitzgerald

(2.62)
# 2,050
Out of 5,143 analysts
1
Total ratings
100%
Success rate
50.72%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yanni Souroutzidis

Karyopharm Therapeutics
Feb 5, 2026
Initiates: Overweight
Price Target: n/a
Current: $10.07
Upside: -